GlaxoSmithKline Pharmaceuticals Limited GLAXO
NSE · India · Health Technology
INR 2,771.10+1.80 (+0.06%)
Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) reports robust revenue growth and strategic advancements in oncology, despite supply challenges and regulatory hurdles.
Despite a sales decline, GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) showcases resilience with improved margins and robust specialty business growth.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.